Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Chitosan dosage regimen to trap fecal oil excretion after peroral lipase inhibitor administration in mice.

Jang Y, Je YT, Yun CW, Chung H.

Int J Biol Macromol. 2017 Jan;94(Pt A):484-491. doi: 10.1016/j.ijbiomac.2016.10.003. Epub 2016 Oct 13.

PMID:
27746355
2.

Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition.

Sangwai M, Sardar S, Vavia P.

Pharm Dev Technol. 2014 Feb;19(1):31-41. doi: 10.3109/10837450.2012.751404. Epub 2012 Dec 24.

PMID:
23259606
3.

Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.

Trouillot TE, Pace DG, McKinley C, Cockey L, Zhi J, Häeussler J, Guerciolini R, Showalter R, Everson GT.

Am J Gastroenterol. 2001 Jun;96(6):1888-94.

PMID:
11421247
4.

Transfer of orlistat through oil-water interfaces.

Tiss A, Lengsfeld H, Hadváry P, Cagna A, Verger R.

Chem Phys Lipids. 2002 Oct;119(1-2):41-9.

PMID:
12270672
5.

[Orlistat: medically induced malabsorption of the fat in the treatment of severe obesity].

Hendel HW, Andersen T.

Ugeskr Laeger. 1999 Nov 1;161(44):6068-72. Review. Danish. No abstract available.

PMID:
10778347
6.

Comparative evaluation of fecal fat excretion induced by orlistat and chitosan.

Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J, Moore R.

Obes Res. 2001 Jun;9(6):364-7.

7.

Pharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules.

Zaid AN, Zohud N, E'layan B, Aburadi T, Jaradat N, Ali I, Hussein F, Ghanem M, Qaddomi A, Abu Zaaror Y.

Drug Des Devel Ther. 2017 Nov 21;11:3291-3298. doi: 10.2147/DDDT.S138926. eCollection 2017.

8.

Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice.

Sumiyoshi M, Kimura Y.

J Pharm Pharmacol. 2006 Feb;58(2):201-7.

PMID:
16451748
9.

Antiobese effects of capsaicin-chitosan microsphere (CCMS) in obese rats induced by high fat diet.

Tan S, Gao B, Tao Y, Guo J, Su ZQ.

J Agric Food Chem. 2014 Feb 26;62(8):1866-74. doi: 10.1021/jf4040628. Epub 2014 Feb 14.

PMID:
24479662
10.

Anti-obesity effects of chitosan and psyllium husk with L-ascorbic acid in guinea pigs.

Jun SC, Jung EY, Hong YH, Park Y, Kang Dh, Chang UJ, Suh HJ.

Int J Vitam Nutr Res. 2012 Apr;82(2):113-20. doi: 10.1024/0300-9831/a000100.

PMID:
23065836
11.

Surface behaviour of bile salts and tetrahydrolipstatin at air/water and oil/water interfaces.

Tiss A, Ransac S, Lengsfeld H, Hadvàry P, Cagna A, Verger R.

Chem Phys Lipids. 2001 May;111(1):73-85.

PMID:
11438285
12.

The physical properties of rectal contents have effects on anorectal continence: insights from a study into the cause of fecal spotting on orlistat.

Fox M, Schwizer W, Menne D, Stutz B, Fried M, Thumshirn M.

Dis Colon Rectum. 2004 Dec;47(12):2147-56.

PMID:
15657667
13.

Investigation of chitosan for decorporation of 60Co in the rat.

Levitskaia TG, Creim JA, Curry TL, Luders T, Morris JE, Sinkov SI, Woodstock AD, Thrall KD.

Health Phys. 2009 Aug;97(2):115-24. doi: 10.1097/01.HP.0000346798.82764.d7.

PMID:
19590271
14.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
16.

Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase.

Kazmi I, Afzal M, Rahman S, Iqbal M, Imam F, Anwar F.

Eur J Pharmacol. 2013 Jun 5;709(1-3):28-36. doi: 10.1016/j.ejphar.2013.02.032. Epub 2013 Mar 13.

PMID:
23500199
17.

Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects.

Ahnen DJ, Guerciolini R, Hauptman J, Blotner S, Woods CJ, Wargovich MJ.

Clin Gastroenterol Hepatol. 2007 Nov;5(11):1291-9. Epub 2007 Oct 24.

PMID:
17920338
18.

Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion.

Ferraz RR, Tiselius HG, Heilberg IP.

Kidney Int. 2004 Aug;66(2):676-82. Erratum in: Kidney Int. 2004 Sep;66(3):1304. Heiberg, Ita Pfeferman [corrected to Heilberg, Ita Pfeferman].

19.

Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.

Bryson A, de la Motte S, Dunk C.

Br J Clin Pharmacol. 2009 Mar;67(3):309-15. doi: 10.1111/j.1365-2125.2008.03311.x. Epub 2008 Sep 19.

20.

Chitosan supplementation and fat absorption in men and women.

Gades MD, Stern JS.

J Am Diet Assoc. 2005 Jan;105(1):72-7.

PMID:
15635349

Supplemental Content

Support Center